Believe it or not, in this week approaching Thanksgiving, we in the United States are faced with a second challenge to Prostate Cancer screening using the PSA test. Malecare wants you to know.
 
The Centers for Medicare and Medicaid Services (CMS) is asking for pubic comment on a clinical quality measure that would probably lead to financial penalties for providers (your doctor) who order a PSA screening test. The measure is based on the PSA screening recommendations of the U.S. Preventative Services Task Force (USPSTF).
 
The USPSTF is the organization responsible for the recommendation against prostate cancer screening. Their May 2012 recommendation reads:
The U.S. Preventive Services Task Force (USPSTF) recommends against prostate-specific antigen (PSA)-based screening for prostate cancer.
 
This recommendation has caused massive controversy throughout our health care system.